Spinal Cord Stimulation in Severe Cases of Complex Regional Pain Syndrome: A Retrospective Cohort Study with Long‐Term Follow‐up

2021 ◽  
Author(s):  
Linda Elise Eriksen ◽  
Astrid Juhl Terkelsen ◽  
Morten Rune Blichfeldt‐Eckhardt ◽  
Jens Christian H Sørensen ◽  
Kaare Meier
Keyword(s):  
Spinal Cord ◽  
Cohort Study ◽  
Complex Regional Pain Syndrome ◽  
Retrospective Cohort Study ◽  
Spinal Cord Stimulation ◽  
Retrospective Cohort ◽  
Pain Syndrome ◽  
Long Term Follow Up

Spinal Cord Stimulation for Complex Regional Pain Syndrome Type I: A Prospective Cohort Study With Long-Term Follow-Up

2013 ◽  
Vol 16 (6) ◽  
pp. 523-529 ◽  
Author(s):  
José W. Geurts ◽  
Helwin Smits ◽  
Marius A. Kemler ◽  
Florian Brunner ◽  
Alfons G. H. Kessels ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Cohort Study ◽  
Spinal Cord Stimulation ◽  
Prospective Cohort ◽  
Pain Syndrome ◽  
Type I ◽  
Syndrome Type ◽  
Long Term Follow Up

Spinal Cord Stimulation Is Effective in Management of Complex Regional Pain Syndrome I: Fact or Fiction

Neurosurgery ◽  
2011 ◽  
Vol 69 (3) ◽  
pp. 566-580 ◽  
Author(s):  
Krishna Kumar ◽  
Syed Rizvi ◽  
Sharon Bishop Bnurs
Keyword(s):  
Quality Of Life ◽  
Spinal Cord ◽  
Functional Status ◽  
Complex Regional Pain Syndrome ◽  
Spinal Cord Stimulation ◽  
Pain Syndrome ◽  
Sf 36

Abstract BACKGROUND: Complex regional pain syndrome (CRPS) I is a debilitating neuropathic pain disorder characterized by burning pain and allodynia. Spinal cord stimulation (SCS) is effective in the treatment of CRPS I in the medium term but its long-term efficacy and ability to improve functional status remains controversial. OBJECTIVE: To evaluate the ability of SCS to improve pain, functional status, and quality of life in the long term. METHODS: We retrospectively analyzed 25 patients over a mean follow-up period of 88 months. The parameters for evaluation were visual analog scale (VAS), Oswestry Disability Index (ODI), Beck Depression Inventory (BDI), EuroQoL-5D (EQ-5D) and Short Form 36 (SF-36), and drug consumption. Evaluations were conducted at point of entry, 3 months, 12 months, and last follow-up at 88 months (mean). RESULTS: At baseline, the mean scores were VAS 8.4, ODI 70%, BDI 28, EQ-5D 0.30, and SF-36 24. In general, maximum improvement was recorded at follow-up at 3 months (VAS 4.8, ODI 45%, BDI 15, EQ-5D 0.57, and SF-36 45). At last follow-up, scores were 5.6, 50%, 19, 0.57, and 40, respectively. Despite some regression, at last follow-up benefits were maintained and found to be statistically significant (P < .001) compared with baseline. Medication usage declined. SCS did not prevent disease spread to other limbs. Best results were achieved in stage I CRPS I, patients under 40 years of age, and those receiving SCS within 1 year of disease onset. CONCLUSION: SCS improves pain, quality of life, and functional status over the long term and consequently merits early consideration in the treatment continuum.

scholarly journals Pain Catastrophizing Does Not Predict Spinal Cord Stimulation Outcomes: A Cohort Study of 259 Patients With Long-Term Follow-Up

2020 ◽  
Author(s):  
Dennis Møgeltoft Poulsen ◽  
Jens Christian Hedemann Sørensen ◽  
Morten Rune Blichfeldt-Eckhardt ◽  
Helga Angela Gulisano ◽  
Anne Lene Høst Knudsen ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Cohort Study ◽  
Spinal Cord Stimulation ◽  
Pain Catastrophizing ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document